Fujian Wanchen Biotechnology Co. Ltd (300972) — Capital Reinvestment Ratio
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥3.63 Billion) in capital expenditures (CN¥77.44 Million). See 300972 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fujian Wanchen Biotechnology Co. Ltd Capital Reinvestment Ratio (2019–2025)
This chart tracks Fujian Wanchen Biotechnology Co. Ltd's Capital Reinvestment Ratio across 7 annual periods. Check 300972 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year Capital Reinvestment Ratio for Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. For live market cap and broader valuation context, see market value of Fujian Wanchen Biotechnology Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥3.63 Billion | CN¥77.44 Million | ▼ -84.5% |
| 2024 | 0.14x | CN¥848.35 Million | CN¥116.65 Million | ▼ -35.7% |
| 2023 | 0.21x | CN¥1.02 Billion | CN¥218.91 Million | ▼ -95.2% |
| 2022 | 4.49x | CN¥70.38 Million | CN¥316.34 Million | ▲ +968.4% |
| 2021 | 0.42x | CN¥98.82 Million | CN¥41.57 Million | ▲ +17.2% |
| 2020 | 0.36x | CN¥156.24 Million | CN¥56.10 Million | ▲ +60.2% |
| 2019 | 0.22x | CN¥177.28 Million | CN¥39.73 Million | — |